Dow Cuts Losses as Value Stocks Ride Vaccine, Stimulus News Higher

Investing.com

Published Dec 02, 2020 12:56PM ET

Updated Dec 02, 2020 02:39PM ET

By Yasin Ebrahim

Investing.com - The Dow cut losses Wednesday led by a rise in value stocks following positive news on Pfizer 's Covid-19 vaccine and optimism for a stimulus relief package.

The Dow Jones Industrial Average rose 0.05%, or 13 points. The S&P 500 was up 0.11%, while the Nasdaq Composite slipped 0.13%.

In a boost to hopes that lawmakers may roll out a fiscal package to support the economy U.S. House Speaker Nancy Pelosi and Senate Minority Leader Chuck Schumer backed the bipartisan $908 billion stimulus deal that includes support for small businesses and unemployed Americans. The deal should be used "as the basis for immediate negotiations,"  Pelosi and Schumer said in a joint statement.

The positive update on stimulus arrived on the back of positive vaccine news after the UK approved temporary emergency use authorization for Pfizer (NYSE:PFE)'s and development partner BioNTech (NASDAQ:BNTX)'s vaccine.

Approval from the U.S. is not far behind, with many expecting the Pfizer vaccine to get approval from the U.S. Food and Drug Administration before year-end.

Renewed action on the value trade in the wake of positive vaccine news – bullish bets on stocks tied to the progress of the economy– also benefited cruise lines, casinos, and airlines.

As well as vaccine optimism, positive comments on a stimulus for the aviation industry lifted sentiment on the sector.

U.S. Treasury Secretary Steven Mnuchin said Wednesday he supported another $20 billion in additional government payroll support for U.S. airlines.

"I think that would be very meaningful in terms of employment and saving the industry," Mnuchin said at a House hearing, according to Reuters.

American Airlines Group (NASDAQ:AAL) and United Airlines (NASDAQ:UAL) were up more than 2%.

On the economic front, a weaker-than-expected private sector jobs report for November was largely downplayed by analysts.

"The ADP employment report showed a 307,00 increase in private employment below our forecast of 750,000... but it also showed that the "broad-based job gains across firm size continued," Morgan Stanley (NYSE:MS) said in a note.

In tech, Salesforce.com (NYSE:CRM) fell 8% after confirming the $27.7 billion acquisition of Slack that will boost its battle against Microsoft (NASDAQ:MSFT) in enterprise technology.

In other news, Palantir Technologies (NYSE:PLTR) fell 14% after Morgan Stanley downgraded the stock to underweight from equal weight, citing little change in the fundamental story of the company since its IPO. 

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes